These secondary antibodies were further conjugated to a novel HRP labeled streptavidin polymer poly HRP strept that consist of multi HRP enzymes for signal amplification via glutathione as a substrate stromectol precio Switching from an aromatase inhibitor to fulvestrant upon early identification of the ESR1 mutation in plasma before disease progression doubled progression free survival in the phase III PADA 1 trial, presented at the 2021 San Antonio Breast Cancer Symposium